NCLT approves merger of Docon Technologies with API Holdings

Nclt Scheme FiledStrategic Transactions View source PDF Explain this filing

THYROCARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.3%Reaction day

₹590.00

prior close

₹590.60

announcement price

After-mkt

timing

Nifty Microcap 250market-0.6%-1.7% vs market

Healthcare Service Provider peers, median of 26sector-0.5%-1.7% vs sector

On the reaction day the stock moved 1.7 pts less than Nifty Microcap 250 and 1.7 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.1

10m

-0.9

15m

-0.8

30m

-1.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.3-0.6-1.7-0.5-1.7

Next day

-2.0+0.0-2.0+0.7-2.8

-2.3+0.7-3.0+0.7-3.0

-2.4+1.1-3.5+0.1-2.5

-3.3+1.6-4.9-0.1-3.2

-3.5+1.5-5.0+0.4-3.9

-6.3+1.4-7.7-0.4-5.9

15d

-3.7+0.4-4.1-1.5-2.2

-9.0-1.4-7.6-5.1-3.9

—————

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 26Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

NCLT Mumbai has sanctioned the amalgamation of Docon Technologies with API Holdings, both promoter group entities. Docon currently holds 51.02% (8.12 crore equity shares) in Thyrocare. Upon the scheme becoming effective, this stake will vest directly in API Holdings in place of Docon. There is no change in aggregate promoter shareholding, which continues at 51.02%. The scheme becomes effective once the NCLT order is filed with the Registrar of Companies.

Likely market impact

Internal promoter group restructuring with no change in total promoter stake (stays at 51.02%). No direct impact on minority shareholders.